Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 500 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Citius Pharmaceuticals Inc | CTXR | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0055 | -0.68% | 0.80 | 04:03:51 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.8055 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 1 | 500 | - | 0.60 - 1.65 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 04:01:58 | formt | 500 | $ 0.80 | USD |
Citius Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 128.87M | 159.09M | - | 0 | -33.69M | -0.21 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Citius Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CTXR Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.81 | 1.04 | 0.73 | 0.7987664 | 1,779,364 | -0.01 | -1.23% |
| 1 Month | 0.741 | 1.07 | 0.7001 | 0.8720475 | 1,196,602 | 0.059 | 7.96% |
| 3 Months | 0.67 | 1.07 | 0.60 | 0.7902425 | 822,036 | 0.13 | 19.40% |
| 6 Months | 0.7593 | 1.07 | 0.60 | 0.7777318 | 702,586 | 0.0407 | 5.36% |
| 1 Year | 1.65 | 1.65 | 0.60 | 1.03 | 1,073,001 | -0.85 | -51.52% |
| 3 Years | 1.69 | 4.56 | 0.60 | 1.96 | 2,010,290 | -0.89 | -52.66% |
| 5 Years | 1.08 | 4.56 | 0.40 | 1.84 | 2,360,458 | -0.28 | -25.93% |
Citius Pharmaceuticals Description
| Citius Pharmaceuticals, Inc. is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, unique prescription products, and stem cell therapy. It is currently advancing four proprietary product candidates: Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory distress syndrome. |
